RORYSA Trademark

Trademark Overview


On Tuesday, January 18, 2011, a trademark application was filed for RORYSA with the United States Patent and Trademark Office. The USPTO has given the RORYSA trademark a serial number of 85220102. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 17, 2018. This trademark is owned by GOLDEN BIOTECHNOLOGY CORPORATION. The RORYSA trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional addit...
rorysa

General Information


Serial Number85220102
Word MarkRORYSA
Filing DateTuesday, January 18, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 17, 2018
Registration Number4085064
Registration DateTuesday, January 10, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2011

Trademark Statements


Goods and ServicesAdjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 17, 2018
Primary Code005
First Use Anywhere DateWednesday, January 19, 2011
First Use In Commerce DateTuesday, July 26, 2011

Trademark Owner History


Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei County 2514
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei County 2514
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei County 2514
TW

Trademark Events


Event DateEvent Description
Friday, August 17, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, January 10, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 10, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, December 7, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 6, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, November 28, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 19, 2011STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 10, 2011USE AMENDMENT FILED
Wednesday, November 16, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 10, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, September 20, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2011PUBLISHED FOR OPPOSITION
Friday, June 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 16, 2011ASSIGNED TO LIE
Thursday, June 2, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 7, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 7, 2011NON-FINAL ACTION E-MAILED
Thursday, April 7, 2011NON-FINAL ACTION WRITTEN
Wednesday, April 6, 2011ASSIGNED TO EXAMINER
Monday, January 24, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 21, 2011NEW APPLICATION ENTERED IN TRAM